Open Access<p>Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma</p>
Author(s) -
Xiucun Wang,
Cheng Wang,
Xiao Lin,
Zhengquan Yu
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s247731
Subject(s) - glioma , blot , flow cytometry , cancer research , immunohistochemistry , metastasis , apoptosis , cell growth , biology , in vivo , cancer , medicine , chemistry , pathology , microbiology and biotechnology , gene , biochemistry , genetics
Rap2c is a member of the Ras superfamily that has been implicated in various types of cancers. However, its role in glioma remains elusive. This study aimed to elucidate the role of Rap2c in glioma and its specific molecular mechanism.